A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer
Status:
Unknown status
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of tegafur/uracil (UFT) plus folinate calcium (leucovorin: LV)
administered orally and UFT plus Krestin (PSK) administered orally enrolling patients with
pTNM stage IIB or III colorectal cancer as subjects in a multicenter collaborative randomized
open-label comparative controlled study and consequently to determine the usefulness of the
above regimens as adjuvant therapy after surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group